下一个

自动播放

Immunotherapy for Metastatic Kidney Cancer Shows Increased Survival

2 意见 • 07/10/23
分享
嵌入
administrator
administrator
订户
0

The immune checkpoint inhibitor Opdivo (nivolumab) has been shown to increase survival for patients with metastatic clear cell kidney cancer (also called renal cell carcinoma, or RCC).

显示更多
0 注释 sort 排序方式
脸书评论

下一个

自动播放